The Economic Impact of IoT-based NPPV Management

Chronic obstructive pulmonary disease (COPD) remains a massive healthcare challenge in India, ranking as the second leading cause of death. For patients suffering from hypercapnic chronic respiratory failure, home noninvasive positive pressure ventilation (NPPV) is a standard treatment. However, recent evidence suggests that IoT-based NPPV management can significantly enhance these outcomes. By integrating telemonitoring and real-time data, this technology improves the communication channel between patients and physicians.

Clinical Benefits and COPD Progression

Researchers recently used a Markov decision analytic model to simulate real-world COPD progression. This model tracked four specific health states: stable periods, non-serious exacerbations, serious exacerbations, and death. The data revealed that IoT-based NPPV management improved quality-adjusted life years (QALYs) by 0.24 per person over a lifetime horizon. Specifically, the system helps clinicians identify early warning signs of respiratory failure, thereby reducing the severity of exacerbation periods.

Cost-Effectiveness for Healthcare Systems

Economic evaluations from the study show an incremental cost-effectiveness ratio (ICER) of approximately ¥15,030.25 per QALY. While the IoT-based NPPV management system involves a slight increase in initial costs, it effectively lowers long-term expenses. The primary cost-saving driver is the reduction in hospitalizations during serious exacerbations. Consequently, the study reported a 93.6% probability of this management style being cost-effective within standard willingness-to-pay thresholds. For the Indian healthcare sector, which seeks to balance high disease burden with resource optimization, such telemonitoring solutions offer a viable path forward.

Frequently Asked Questions

How does IoT-based NPPV management improve patient outcomes?

The system strengthens telemonitoring integration. This allows for continuous data flow, which helps physicians make timely adjustments to ventilation settings and intervention strategies before a patient requires hospitalization.

Is IoT-based NPPV management economically viable for chronic care?

Yes. Although it increases management costs slightly, it significantly reduces the financial burden of serious exacerbations and hospital stays, resulting in a favorable cost-per-QALY ratio.

Who benefits most from IoT-based respiratory telemonitoring?

The technology is most beneficial for patients with stable COPD who also experience hypercapnic chronic respiratory failure and require long-term home ventilation support.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Feng R et al. Cost-Effectiveness of Internet of Things-Based Management of Home Noninvasive Positive Pressure Ventilation in Patients With Chronic Obstructive Pulmonary Disease and Hypercapnic Chronic Respiratory Failure: Trial-Based Economic Evaluation. JMIR Mhealth Uhealth. 2026 May 14. doi: 10.2196/71340. PMID: 42133996.

Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2024 Report).

Salvi S, Agrawal A, et al. The burden of chronic respiratory diseases and their heterogeneity across the states of India: the Global Burden of Disease Study 1990–2016. Lancet Global Health. 2018.